No takes yet. Share an insight, caveat, or question.
Review highlights intestinal permeability biomarkers' role in predicting metabolic disease outcomes, suggesting therapeutic approaches.
Cătană et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: